Skip to main content
Livermore
Livermore
ZHEN

SEI Investments Co

SEC CIK
0000350894
Latest filing
Aug 14, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by SEI Investments Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q2 2026)
59,230
Value
$99.5K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of PACB by SEI Investments Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202659,230$99.5K<0.1%−107,593−64.5%ReducedHolders
Q1 2026166,823$220.2K<0.1%+166,823NewHolders
Q1 20250$00.0%−28,004−100.0%Sold outHolders
Q4 202428,004$51.2K<0.1%−91,853−76.6%ReducedHolders
Q3 2024119,857$203.8K<0.1%−523,579−81.4%ReducedHolders
Q2 2024643,436$881.5K<0.1%−914,278−58.7%ReducedHolders
Q1 20241,557,714$5.84M<0.1%−282,359−15.3%ReducedHolders
Q4 20231,840,073$18.1M<0.1%+642,400+53.6%AddedHolders
Q3 20231,197,673$10.0M<0.1%−250,019−17.3%ReducedHolders
Q2 20231,447,692$19.3M<0.1%−708,474−32.9%ReducedHolders
Q1 20232,156,166$25.0M<0.1%−495,421−18.7%ReducedHolders
Q4 20222,651,587$21.7M<0.1%−841,675−24.1%ReducedHolders
Q3 20223,493,262$20.3M<0.1%−356,287−9.3%ReducedHolders
Q2 20223,849,549$17.0M<0.1%−86,738−2.2%ReducedHolders
Q1 20223,936,287$35.8M0.1%+1,261,333+47.2%AddedHolders
Q4 20212,674,954$54.7M0.1%+146,263+5.8%AddedHolders
Q3 20212,528,691$64.6M0.1%−20,534−0.8%ReducedHolders
Q2 20212,549,225$89.1M0.2%+436,096+20.6%AddedHolders
Q1 20212,113,129$70.4M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.